Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HCY9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.257 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.211 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.503 |
DOC_CYCLIN_yClb1_LxF_4 | 75 | 81 | PF00134 | 0.243 |
LIG_Actin_WH2_2 | 50 | 66 | PF00022 | 0.267 |
LIG_Actin_WH2_2 | 77 | 94 | PF00022 | 0.258 |
LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.243 |
LIG_BRCT_BRCA1_1 | 76 | 80 | PF00533 | 0.279 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.537 |
LIG_EH1_1 | 79 | 87 | PF00400 | 0.302 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.327 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.407 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.355 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.327 |
LIG_GBD_Chelix_1 | 78 | 86 | PF00786 | 0.267 |
LIG_NRBOX | 2 | 8 | PF00104 | 0.411 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.243 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.457 |
LIG_SUMO_SIM_par_1 | 105 | 111 | PF11976 | 0.302 |
LIG_UBA3_1 | 37 | 44 | PF00899 | 0.355 |
MOD_CK1_1 | 28 | 34 | PF00069 | 0.425 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.367 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.312 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.477 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.220 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.302 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.361 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.241 |
MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.308 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.328 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.314 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.244 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.245 |
MOD_PIKK_1 | 45 | 51 | PF00454 | 0.234 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.380 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.460 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.298 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.396 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.307 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.401 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.254 |
TRG_DiLeu_BaLyEn_6 | 14 | 19 | PF01217 | 0.407 |
TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.457 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IWN9 | Bodo saltans | 60% | 100% |
A0A1X0NYC0 | Trypanosomatidae | 64% | 96% |
A0A3S7WXT4 | Leishmania donovani | 88% | 100% |
A0A422N7S4 | Trypanosoma rangeli | 62% | 99% |
A0NGI1 | Anopheles gambiae | 33% | 86% |
A4I0H4 | Leishmania infantum | 88% | 100% |
A7YW81 | Bos taurus | 33% | 86% |
C9ZV99 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
Q4QB36 | Leishmania major | 88% | 100% |
Q54ZG7 | Dictyostelium discoideum | 38% | 95% |
Q8WY98 | Homo sapiens | 31% | 74% |